Carol A. Surface - 01 Aug 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP, Chief HR Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
03 Aug 2022, 17:34:41 UTC
Previous filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +5,157 +25% $0.000000 26,193 01 Aug 2022 Direct F1
holding MDT Ordinary Shares 576 01 Aug 2022 NQ Ret Plan Sup

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Award $0 +12,893 $0.000000 12,893 01 Aug 2022 Performance Share Units 12,893 Direct F2, F3, F4
transaction MDT Stock Option (Right to Buy) Award $0 +40,754 $0.000000 40,754 01 Aug 2022 Ordinary Shares 40,754 $93.08 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F2 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F3 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 12,893 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F4 Vests on August 1, 2025.
F5 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.